Ferrer is dedicated to advancing research and development in the pharmaceutical sector, particularly focusing on severe and debilitating diseases. Their R&D strategy emphasizes the creation of transformative therapeutic solutions, particularly in the areas of pulmonary vascular and interstitial lung diseases, as well as neurological disorders. The company employs innovative drug delivery approaches and state-of-the-art digital technologies to enhance treatment efficacy and improve patient quality of life. Their commitment to addressing unmet medical needs is reflected in their patient-centric pipeline, which includes multiple product candidates aimed at providing impactful solutions for chronic and acute conditions.

A key technology utilized by Ferrer is the Staccato® One Breath Technology™ (OBT), which enables non-invasive delivery of medications through a handheld inhaler. This system vaporizes pharmaceutical ingredients rapidly, allowing for quick absorption into the bloodstream and therapeutic onset. The Staccato technology has been validated through regulatory approvals and is currently being developed for various applications, including treatments for Parkinson's disease and cyclic vomiting syndrome. Additionally, Ferrer’s R&D capabilities extend to diverse formulation technologies, such as extended release and injectable depots, aimed at enhancing existing therapies and creating more effective treatment options for patients.

Spain

At Ferrer, we focus on identifying projects with differential value. The R&D team aims to develop and deliver transformative therapeutic solutions for people living with severe and debilitating diseases. 

Innovation is an inherent part of our pharmaceutical development, and we have always upheld our commitment in searching for and developing new treatment alternatives aimed at addressing unmet medical needs in order to improve the patients' quality of life and creating value for physicians, health systems and society at large.

We do this in two main areas: Pulmonary vascular and interstitial lung diseases & Neurological disorders

Ferrer

Company Details